Modification of BRCA1-associated breast cancer risk by HMMR overexpressionFrancesca Mateo, Miguel Ángel Pujana, Zhengcheng He et al.|Nature Communications|2022Cited by 53
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosisCarmen Herranz, Aslihan Ugun‐Klusek, Nadia García et al.|EMBO Molecular Medicine|2021Cited by 21
Immune Cell Associations with Cancer RiskLuís Palomero, Miguel Ángel Pujana, Iván Galván‐Femenía et al.|iScience|2020Cited by 14
EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell CarcinomaLuís Palomero, Miguel Ángel Pujana, Lubomir Bodnar et al.|Cancers|2020Cited by 13
Biological basis of extensive pleiotropy between blood traits and cancer riskMiguel Ángel Pardo-Cea, Miguel Ángel Pujana, Xavier Farré et al.|Genome Medicine|2024Cited by 13